Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05154773 · ClinicalTrials.gov registry record · NA

Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication

A NA study of End Stage Renal Disease and Chronic Kidney Diseases, sponsored by State University of New York at Buffalo.

Active
Registry status
NA
Development phase
422
Enrollment target
1
Study location

NCT05154773 is a NA study of End Stage Renal Disease and Chronic Kidney Diseases that is active but no longer recruiting, run by State University of New York at Buffalo. The registered enrollment target is 422 participants, below the 829-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05154773, a NA study of End Stage Renal Disease and Chronic Kidney Diseases, is active but no longer recruiting, sponsored by State University of New York at Buffalo.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
422 participants
Enrollment target
1
Study location

Study Summary

The study is a- 2-arm randomized controlled trial among patients presenting for kidney transplant evaluation at a single transplant center to compare the effects of a patient-based self-learning and outreach intervention about living-donor kidney transplantation (KidneyTIME) versus usual care for living-donor kidney transplant knowledge, concerns, readiness, access behaviors, and living-donor inquiries over 12 months follow-up. Following consent and baseline assessment, participants were randomized, stratified by self-reported race, with equal allocation to 2 treatment arms: the KidneyTIME intervention and usual care.

Interventions

  • BEHAVIORAL Kidney donation and transplant information made easy

Study Locations (1)

New York

  • Erie County Medical Center - Buffalo

Trial Details

FieldValue
Enrollment Target 422 participants
Start Date 2022-04-01
Est. Completion 2026-03-30
Phase NA

What the Registry Record Tells You About NCT05154773

The ClinicalTrials.gov registry entry for NCT05154773 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 422 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 829-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (49% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which Kidney donation and transplant information made easy is the first listed.

NCT05154773 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05154773 about?

NCT05154773 is a clinical study titled "Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication". The study is a- 2-arm randomized controlled trial among patients presenting for kidney transplant evaluation at a single transplant center to compare the effects of a patient-based self-learning and outreach intervention about living-donor kidney transplantation (KidneyTIME) versus usual care for li...

What is the current status of trial NCT05154773?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 422 participants. The study started on 2022-04-01. Estimated completion is 2026-03-30.

What conditions does trial NCT05154773 study?

This clinical trial studies the following conditions: End Stage Renal Disease, Chronic Kidney Diseases.

What interventions are being tested in trial NCT05154773?

The interventions under investigation include: Kidney donation and transplant information made easy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05154773?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05154773 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.